Background
Materials and Methods
Patients
Median | Range | |
---|---|---|
Age
| 62.6 years | 35.3 - 77.9 years |
Time to SIRT after primary diagnosis
| 25 months | 6-140 |
Number
|
Percentage (%)
| |
Patients
| 49 | 100 |
Gender
| ||
Female | 16 | 32.7 |
Male | 33 | 67.3 |
Localisation of primary tumor
| ||
Colon | 11 | 22.5 |
Sigma | 22 | 44.0 |
Rectum | 16 | 32.5 |
Chemotherapies before SIRT
| ||
FOLFOX | 42 | 85.7 |
FOLFIRI | 47 | 95.9 |
Therapy response
| ||
REM | 9 | 18.4 |
SD | 5 | 10.2 |
PD | 35 | 71.4 |
Progression defining | ||
liver metastases | 19 | 54.3 |
extrahepatic manifestation | 6 | 17.1 |
deceased | 10 | 28.6 |
One year survival*
| ||
Yes | 22 | 45.8 |
No | 26 | 54.2 |
Median
|
95% Conf. Interval
| |
Overall survival
| 8.8 months | 5.1-18.1 |
Treatment procedures
Classification of response to therapy
Sample collection and assays
Statistics
Results
Reference value (95th perc. of healthy) | 0 hours | 3 hours | 6 hours | 24 hours | 48 hours | |
---|---|---|---|---|---|---|
Median | Median | Median | Median | Median | ||
Range | Range | Range | Range | Range | ||
Nucleo-somes [ng/mL] |
190.5
|
197.6
|
237.4
|
758.5
|
596.0
| |
< 36
| 5.0-1624 | 34.8-2501 | 40.7-2064 | 21.7-4334 | 51.7-2547 | |
CYFRA 21-1
[ng/mL] |
10.9
|
9.3
|
8.8
|
28.6
|
27.5
| |
< 2.2
| 0.8-246.0 | 0.9-240.0 | 1.1-230.0 | 1.0-811.0 | 1.5-638.0 | |
CEA
[ng/mL] |
330.0
|
343.5
|
356.5
|
351.0
|
433.0
| |
< 3.4
| 2.0-31620 | 1.9-33010 | 1.9-16980 | 1.6-36120 | 1.6-37550 | |
CA 19-9 [U/mL] |
40.0
|
41.6
|
49.7
|
48.7
|
56.4
| |
< 37
| 2.4-11530 | 2.3-24400 | 2.2-8748 | 2.4-18550 | 2.3-17000 | |
LDH
[U/L] |
407.0
|
486.5
|
585.0
| |||
< 250
| 178.0-3068 | 143.0-2923 | 142.0-3585 | |||
CRP
[mg/dL] |
1.3
|
1.3
|
4.6
| |||
< 0.5
| 0.1-20.3 | 1.3-21.8 | 0.1-16.3 | |||
CHE
[kU/L] |
7.3
|
6.3
|
5.9
| |||
5.0-13.3
| 2.8-11.1 | 2.8-11.1 | 5.9-10.5 | |||
AST
[U/L] |
52.0
|
74.5
|
68.5
| |||
< 33
| 24.0-190.0 | 15.0-339.0 | 19.0-317.0 | |||
ALT
[U/L] |
34.5
|
46.0
|
48.5
| |||
< 35
| 15.0-268.0 | 14.0-178.0 | 13.0-136.0 | |||
Bilirubin
[mg/dL] |
0.7
|
1.0
|
1.2
| |||
< 1.0
| 0.3-1.9 | 0.4-2.2 | 0.4-2.8 | |||
AP
[U/L] |
160.0
|
148.0
|
156.0
| |||
< 135
| 81.0-742.0 | 63.0-655.0 | 61.0-630.0 | |||
GGT
[U/L] |
183.5
|
165.5
|
168.5
| |||
< 38
| 33.0-712.0 | 31.0-577.0 | 31.0-653.0 | |||
Amylase
[U/L] |
58.0
|
44.0
|
46.5
| |||
< 100
| 20.0-136.0 | 20.0-429.0 | 20.0-519.0 | |||
Lipase
[U/L] |
26.0
|
18.0
|
20.0
| |||
< 60
| 3.0-263.0 | 3.0-585.0 | 3.0-495.0 |
Responder | Non-Responder | |||||
---|---|---|---|---|---|---|
Marker | Time [hours] | Median | Range | Median | Range | p-Value |
Nucleosomes
[ng/mL] | 0 |
198.5
| 17.4-1624 |
174.7
| 5.0-1617 | 0.991 |
24 |
239.1
| 55.6-1225 |
844.8
| 21.7-4334 |
0.003
| |
48 |
677.2
| 51.7-2095 |
594.9
| 133.3-2547 | 0.851 | |
CYFRA 21-1
[ng/mL] | 0 |
6.9
| 0.8-32.8 |
14.0
| 1.3-246.0 |
0.031
|
24 |
28.4
| 1.0-118.0 |
30.8
| 2.9-811.0 | 0.493 | |
48 |
19.6
| 1.5-404.0 |
28.5
| 2.6-638.0 | 0.293 | |
CEA
[ng/mL] | 0 |
162.0
| 4.0-986.0 |
557.0
| 2.0-31620 |
0.037
|
24 |
265.5
| 2.6-5011 |
540.5
| 1.6-36120 | 0.087 | |
48 |
229.5
| 2.2-4073 |
524.0
| 1.6-37550 | 0.063 | |
CA 19-9
[U/L] | 0 |
18.6
| 2.4-159.0 |
148.0
| 2.4-11530 |
0.001
|
24 |
17.9
| 2.5-298.0 |
158.0
| 2.4-18550 |
0.004
| |
48 |
20.9
| 2.4-260.0 |
187.5
| 2.3-17000 |
0.002
| |
LDH
[U/L] | 0 |
349.0
| 178.0-544.0 |
529.5
| 220.0-3068 |
0.011
|
24 |
450.0
| 143.0-1117 |
532.0
| 148.0-2923 | 0.522 | |
48 |
572.0
| 142.0-1488 |
607.5
| 168.0-3585 | 0.434 | |
CRP
[mg/dL] | 0 |
0.9
| 0.3-5.1 |
2.4
| 0.1-20.3 | 0.227 |
24 |
1.1
| 0.1-2.8 |
2.8
| 0.2-21.8 | 0.159 | |
48 |
4.4
| 0.1-16.3 |
4.6
| 0.3-15.1 | 0.507 | |
AST
[U/L] | 0 |
37.5
| 24.0-94.0 |
56.0
| 24.0-190.0 |
0.037
|
24 |
111.0
| 32.0-169.0 |
69.0
| 15.0-339.0 | 0.782 | |
48 |
85.0
| 33. 0-179.0 |
66.0
| 19.0-317.0 | 0.912 | |
ALT
[U/L] | 0 |
38.0
| 15.0-63.0 |
30.0
| 15.0-268.0 | 0.658 |
24 |
52.0
| 26.0-131.0 |
37.0
| 14.0-178.0 | 0.108 | |
48 |
54.0
| 23.0-112.0 |
34.0
| 13.0-136.0 | 0.113 | |
GGT
[U/L] | 0 |
183.5
| 44. 0-432.0 |
189.0
| 33.0-712.0 | 0.782 |
24 |
168.5
| 46.0-391.0 |
164.0
| 31.0-577.0 | 0.965 | |
48 |
177.5
| 60.0-406.0 |
170.0
| 31.0-653.0 | 0.903 | |
AP
[U/L] | 0 |
153.0
| 89.0-569.0 |
193.0
| 81.0-742.0 | 0.559 |
24 |
156.0
| 78.0-588.0 |
151.0
| 63.0-655.0 | 0.707 | |
48 |
156.0
| 77.0-504.0 |
164.0
| 61. 0-630.0 | 0.674 | |
Bilirubin
[mg/dL] | 0 |
0.7
| 0.3-1.4 |
0.8
| 0.3-1.9 | 0.438 |
24 |
0.9
| 0.4-1.7 |
1.0
| 0.4-2.2 | 0.920 | |
48 |
1.1
| 0.5-2.4 |
1.2
| 0.4-2.8 | 0.799 | |
CHE
[kU/L] | 0 |
8.3
| 4.9-11.1 |
6.5
| 2.8-10.8 |
0.017
|
24 |
7.1
| 5.1-11.1 |
5.7
| 2.8-10.4 |
0.009
| |
48 |
6.9
| 4.5-10.5 |
5.3
| 2.3-9.7 |
0.006
| |
Amylase
[U/L] | 0 |
64.5
| 20.0-105.0 |
54.0
| 24.0-136.0 | 0.346 |
24 |
45.5
| 21.0-79.0 |
44.0
| 20.0-429.0 | 0.833 | |
48 |
50.5
| 20.0-58.0 |
46.0
| 23.0-519.0 | 0.842 | |
Lipase
[U/L] | 0 |
27.0
| 3.0-149.0 |
25.0
| 3.0-263.0 | 0.725 |
24 |
17.5
| 4.0-33.0 |
18.0
| 3.0-585.0 | 0.773 | |
48 |
16.5
| 3.0-42.0 |
22.0
| 3.0-495.0 | 0.330 |
Biomarker | Time | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | p-value | ||||
---|---|---|---|---|---|---|---|---|---|---|
Median survival [months] | 95% Confi. Interval | Median survival [months] | 95% Confi. Interval | Median survival [months] | 95% Confi. Interval | Median survival [months] | 95% Confi. Interval | Log-rank | ||
Nucleosomes [ng/mL] | 0 h | < 83 | 83-190 | 191-415 | > 415 | 0.1275 | ||||
17.3
| 1.5 - |
8.2
| 4.6 - |
13.8
| 3.2-23.8 |
6.0
| 1.5-15.4 | |||
24 h | < 384 | 384-751 | 752-1232 | > 1232 |
0.0004
| |||||
23.8
| 4.9-23.8 |
8.0
| 2.5 - |
13.8
| 4.0-20.6 |
5.1
| 1.4-6.1 | |||
CYFRA 21-1
[ng/mL] | 0 h | < 5.3 | 5.3-10.0 | 10.0-32 | > 32.8 |
< .0001
| ||||
20.6
| 8.2 - | 4.9 - |
7.0
| 2.8-18.8 |
3.1
| 1.4-5.1 | ||||
24 h | < 13 | 13-28 | 29-74 | > 74 |
0.0009
| |||||
20.6
| 8.2-23.8 |
6.3
| 3.4 - |
6.2
| 3.1 - |
4.6
| 1.4-15.0 | |||
CEA
[U/L] | 0 h | < 55 | 55-320 | 321-1041 | > 1041 |
0.0002
| ||||
20.6
| 3.1 - |
19.6
| 5.6 - |
8.3
| 4.2-18.8 |
3.1
| 1.4-6.1 | |||
24 h | < 85 | 85-351 | 352-982 | > 982 |
0.0002
| |||||
20.6
| 8.2-23.8 |
19.6
| 4.2 - |
5.5
| 2.5-8.8 |
4.9
| 1.5-15.0 | |||
CA 19-9
[U/L] | 0 h | < 10 | 10-40 | 41-285 | > 285 |
0.0006
| ||||
15.0
| 3.1 - |
23.8
| 8.2 - |
6.6
| 2.8 - |
4.9
| 1.4-6.2 | |||
24 h | < 10 | 10-48 | 49-285 | > 285 |
0.0096
| |||||
15.4
| 3.1 - |
17.8
| 4.2-23.8 |
6.6
| 2.8 - |
5.5
| 1.4-11.0 | |||
CRP
[mg/dL] | 0 h | < 0.5 | 0.5-1.3 | 1.4-8.3 | > 8.3 |
< .0001
| ||||
23.8
| 19.6 - |
14.4
| 3.4 - |
6.8
| 4.4-15.0 |
3.1
| 1.4-5.1 | |||
24 h | < 0.7 | 0.7-1.3 | 1.4-6.4 | > 6.4 |
< .0001
| |||||
23.8
| 11.0-23.8 | 4.7 - |
8.8
| 5.8-15.4 |
3.0
| 1.4-5.1 | ||||
LDH
[U/L] | 0 h | < 299 | 299-393 | 394-604 | > 604 |
< .0001
| ||||
20.6
| 8.2 - |
15.4
| 4.7 - |
8.8
| 1.5-23.8 |
3.2
| 1.5-5.0 | |||
24 h | < 336 | 336-486 | 487-878 | > 878 |
0.0002
| |||||
23.8
| 8.2 - |
11.0
| 4.4 - |
6.8
| 4.6-16.8 |
2.8
| 1.4-15.0 | |||
AST
[U/L] | 0 h | < 35 | 35-52 | 53-66 | > 66 |
< .0001
| ||||
20.6
| 15.0 - |
13.8
| 5.0 - |
7.3
| 4.6-15.0 |
3.0
| 1.4-4.2 | |||
24 h | < 48 | 48-74 | 75-135 | > 135 |
0.0004
| |||||
11.0 - |
6.3
| 4.6-19.6 |
5.6
| 2.8-15.4 |
3.4
| 1.5-15.0 | ||||
ALT
[U/L] | 0 h | < 26 | 26-34 | 35-50 | > 50 | 0.0773 | ||||
18.8
| 5.2 - |
7.8
| 3.1 - |
13.8
| 5.1-15.4 |
3.8
| 1.5-23.8 | |||
24 h | < 30 | 30-46 | 47-64 | > 64 | 0.0824 | |||||
20.6
| 5.2 - |
5.5
| 4.4-15.0 |
15.0
| 2.6-19.6 |
4.1
| 1.5 - | |||
CHE
[kU/L] | 0 h | < 5.8 | 5.8-7.3 | 7.4-8.4 | > 8.4 |
0.0013
| ||||
5.1
| 1.5-6.2 |
5.9
| 2.8 - |
8.2
| 4.0-19.6 |
28.8
| 11.0-23.8 | |||
24 h | < 5.1 | 5.1-6.3 | 6.4-7.6 | > 7.6 |
0.0002
| |||||
4.7
| 1.4-6.8 |
5.4
| 2.5-20.6 |
23.8
| 4.4 - |
18.8
| 8.2 - | |||
GGT
[U/L] | 0 h | < 110 | 110-183 | 184-282 | > 282 |
0.0034
| ||||
16.7
| 5.9 - |
18.8
| 4.4-20.6 |
11.0
| 2.8-15.4 |
4.4
| 2.5-7.8 | |||
24 h | < 94 | 94-165 | 166-274 | > 274 |
0.0101
| |||||
17.3
| 6.8 - |
12.5
| 4.4-20.6 |
15.0
| 2.8 - |
4.8
| 2.5-7.8 | |||
AP
[U/L] | 0 h | < 114 | 114 - 160 | 161 - 321 | > 321 |
< .0001
| ||||
20.6
| 8.2 - |
18.8
| 4.6 - 23.8 |
6.2
| 3.2 - |
4.2
| 1.5 - 5.5 | |||
24 h | < 98 | 98 - 148 | 149 - 265 | > 265 |
< .0001
| |||||
23.8
| 8.2 - |
13.8
| 4.6 - 19.6 |
7.8
| 3.4 - 18.8 |
3.7
| 4.1 - 6.2 | |||
Bilirubin [mg/dL] | 0 h | < 0.5 | 0.5 - 0.7 | 0.8 - 1.2 | > 1.2 | 0.2393 | ||||
14.4
| 4.4 - |
11.0
| 2.8 - |
18.8
| 5.1 - |
4.4
| 1.5 - 15.0 | |||
24 h | < 0.8 | 0.8 - 1.0 | 1.1 - 1.8 | > 1.8 | 0.3335 | |||||
10.3
| 4.0 - 19.6 |
15.4
| 4.6 - |
5.9
| 2.5 - |
8.2
| 1.5 - 23.8 | |||
Amylase
[U/L] | 0 h | < 44 | 44 - 58 | 59 - 75 | > 75 |
0.0102
| ||||
5.2
| 1.4 - 18.8 |
7.5
| 3.2 - 19.6 |
17.4
| 2.5 - 23.8 | 5.8 - | ||||
24 h | < 35 | 35 - 44 | 44 - 63 | > 63 |
0.0030
| |||||
5.2
| 3.2 - 15.4 |
6.2
| 3.1 - |
15.0
| 2.8 - |
20.6
| 1.5 - | |||
Lipase
[U/L] | 0 h | < 13 | 13 - 26 | 27 - 38 | > 38 | 0.5314 | ||||
5.7
| 1.5 - |
18.8
| 2.8 - |
8.8
| 4.0 - |
13.0
| 3.4 - 19.6 | |||
24 h | < 10 | 10- 18 | 18 - 28 | > 28 | 0.6226 |
Parameter | Coefficient | Hazard-Ratio | 95%-Conf Interval | Chi-Square | p-value | AIC | |
---|---|---|---|---|---|---|---|
Model 1 Only pretherapeutic values
|
CRP
(0 h)
| 0.469 |
1.6
| 1.3-2.0 | 16.5 |
< 0.0001
| 187 |
AST
(0 h)
| 0.917 |
2.5
| 1.4-4.4 | 10.3 |
0.0013
| ||
Model 2 Pretherapeutic and 24 h values
|
CRP
(0 h)
| 0.323 |
1.4
| 1.1-1.8 | 6.6 |
0.0104
| 176 |
AST
(0 h)
| 1.351 |
3.9
| 2.0-7.5 | 16 |
< 0.0001
| ||
Nucleosomes (24 h) | 0.565 |
1.8
| 1.2-2.5 | 10.4 |
0.0012
|